American Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533K | Buy |
7,721
+2,356
| +44% | +$163K | 0.05% | 154 |
|
|
2025
Q1 | $373K | Sell |
5,365
-8,224
| -61% | -$571K | 0.09% | 97 |
|
|
2024
Q4 | $1.17M | Buy |
13,589
+864
| +7% | +$74.3K | 0.09% | 112 |
|
|
2024
Q3 | $1.52M | Buy |
12,725
+7,402
| +139% | +$881K | 0.13% | 81 |
|
|
2024
Q2 | $760K | Sell |
5,323
-27
| -0.5% | -$3.85K | 0.06% | 100 |
|
|
2024
Q1 | $687K | Sell |
5,350
-786
| -13% | -$101K | 0.06% | 121 |
|
|
2023
Q4 | $635K | Buy |
6,136
+122
| +2% | +$12.6K | 0.05% | 121 |
|
|
2023
Q3 | $547K | Sell |
6,014
-980
| -14% | -$89.1K | 0.04% | 144 |
|
|
2023
Q2 | $566K | Sell |
6,994
-200
| -3% | -$16.2K | 0.04% | 206 |
|
|
2023
Q1 | $572K | Sell |
7,194
-750
| -9% | -$59.7K | 0.04% | 192 |
|
|
2022
Q4 | $538K | Sell |
7,944
-720
| -8% | -$48.7K | 0.05% | 202 |
|
|
2022
Q3 | $432K | Sell |
8,664
-400
| -4% | -$19.9K | 0.04% | 223 |
|
|
2022
Q2 | $505K | Buy |
9,064
+1,600
| +21% | +$89.1K | 0.04% | 213 |
|
|
2022
Q1 | $414K | Buy |
+7,464
| New | +$414K | 0.03% | 280 |
|